Literature DB >> 16005803

Smoker awareness of and beliefs about supposedly less-harmful tobacco products.

Richard J O'Connor1, Andrew Hyland, Gary A Giovino, Geoffrey T Fong, K Michael Cummings.   

Abstract

BACKGROUND: Cigarette manufacturers in the United States have begun marketing cigarette brands claiming to reduce smokers' exposure to selected toxins in tobacco smoke. Little data exist on smokers' awareness, use, and beliefs about these products.
METHODS: Data from the U.S. arm of the International Tobacco Control Policy Four-Country Survey (ITC-4), a telephone survey of 2028 adult current cigarette smokers in the United States conducted between May and September 2003, were analyzed. Respondents were asked to report their awareness, beliefs, and use of products marketed as less harmful than traditional cigarettes and of smokeless tobacco (SLT) products.
RESULTS: Close to 39% of smokers were aware of "less-harmful" cigarettes, but only 27% of them could name a specific brand of such cigarettes. The brand named most often was Quest (25.7%), followed by Eclipse (7.6%), Winston (5.7%), herbal cigarettes (3.3%), "smoke-free" cigarettes (2.9%), Marlboro Blend #27 (1.9%), and Omni (1.9%). Of those who named a brand, 25% believed such products were less harmful than "ordinary cigarettes." In contrast, 82% of cigarette smokers were aware of SLT products, but only 10.7% of these believed that SLTs were less harmful than ordinary cigarettes.
CONCLUSIONS: Smokers hold beliefs about the relative safety of supposedly less-harmful tobacco products that are opposite to existing scientific evidence. These results highlight the need to educate smokers about the risks of alternatives to conventional cigarettes, and the need to regulate the advertising and promotion of such alternatives.

Entities:  

Mesh:

Year:  2005        PMID: 16005803     DOI: 10.1016/j.amepre.2005.04.013

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  44 in total

1.  A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Authors:  Andrea R Vansickel; Caroline O Cobb; Michael F Weaver; Thomas E Eissenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Food and Drug Administration tobacco regulation and product judgments.

Authors:  Annette R Kaufman; Lila J Finney Rutten; Mark Parascandola; Kelly D Blake; Erik M Augustson
Journal:  Am J Prev Med       Date:  2015-02-25       Impact factor: 5.043

3.  Perceptions of relative risk of snus and cigarettes among US smokers.

Authors:  Lucy Popova; Pamela M Ling
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

4.  New tobacco products: do smokers like them?

Authors:  R S Caraballo; L L Pederson; N Gupta
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

5.  Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products.

Authors:  Lois Biener; Karen Bogen; Gregory Connolly
Journal:  Tob Control       Date:  2007-10       Impact factor: 7.552

6.  A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit.

Authors:  Matthew J Carpenter; Kevin M Gray
Journal:  Nicotine Tob Res       Date:  2010-01-06       Impact factor: 4.244

7.  Perceived Health Risks of Snus and Medicinal Nicotine Products.

Authors:  Dorothy K Hatsukami; R I Vogel; Herb H Severson; Joni A Jensen; Richard J O'Connor
Journal:  Nicotine Tob Res       Date:  2015-09-18       Impact factor: 4.244

Review 8.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 9.  Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods.

Authors:  Vaughan W Rees; Jennifer M Kreslake; K Michael Cummings; Richard J O'Connor; Dorothy K Hatsukami; Mark Parascandola; Peter G Shields; Gregory N Connolly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Interviews with smokers about smokeless tobacco products, risk messages and news articles.

Authors:  Olivia A Wackowski; M Jane Lewis; Cristine D Delnevo
Journal:  Tob Control       Date:  2015-11-17       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.